Database for patients with lower urinary tract dysfunction due to neurological issues

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to systematically collect and analyze data from patients suffering from lower urinary tract dysfunction related to neurological diseases or injuries at the University of Zürich. The study focuses on various symptoms such as detrusor overactivity and voiding dysfunction, which significantly affect patients' quality of life. By gathering clinical, video-urodynamic, and radiological data, the research seeks to improve understanding and management of these conditions. The ultimate goal is to enhance treatment outcomes and long-term follow-up for affected patients.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* patient of Balgrist University Hospital
* patient of University Hospital Zürich
* urodynamic examination
* written informed consent

Exclusion Criteria:

* no written informed consent

Where it's running

• Spinal Cord Injury Center & Research, University of Zürich, Balgrist University Hospital
  Zurich, Canton of Zurich, Switzerland Recruiting

Study contacts

• Principal investigator: Thomas M Kessler — Universitätsklinik Balgrist
• Study coordinator: Thomas M Kessler, MD
• Email: thomas.kessler@balgrist.ch
• Phone: +41 44 386 39 07

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Investigational Intermittent Catheter: First Look at Safety and Usability

  This study tests a new intermittent catheter in adult men who already self-catheterize to see if it is safe and easy to use compared with their current catheter.

  Recruiting Hollister Incorporated · Libertyville, Illinois · NCT07714694

• Patient and caregiver perspectives on bladder instillations for urinary symptoms

  This project talks with adults who have neurogenic bladder and their caregivers to see what they prefer and experience with bladder instillations of Lactobacillus, gentamicin, or both.

  Recruiting Medstar Health Research Institute · Washington D.C., District of Columbia · NCT07390591

• Intravesical Lactobacillus crispatus for urinary health in people with neurogenic bladder

  This study will test whether putting Lactobacillus crispatus into the bladder can help reduce urinary symptoms and urinary tract infections in adults with neurogenic lower urinary tract dysfunction who use intermittent catheters.

  Recruiting Early Phase 1 Medstar Health Research Institute · Washington D.C., District of Columbia · NCT07308808

• Evaluating OM-89 for reducing antibiotic use in urinary tract infections for patients with neurogenic bladder

  This study is testing if a new non-antibiotic treatment called OM-89 can help people with neurogenic bladder reduce their urinary tract infections and the need for antibiotics.

  Recruiting Phase 3 Centre Hospitalier Universitaire Dijon · Dijon · NCT06588010

• Improving pelvic rehabilitation after spinal cord injury with epidural stimulation

  This study is testing if using a special device to stimulate the spinal cord can help people with spinal cord injuries improve their bladder and bowel function through pelvic rehabilitation.

  Recruiting University College, London · Stanmore · NCT06515223

• Using Chlorhexidine Gluconate to improve outcomes for patients with chronic suprapubic catheters

  This study is testing if a special solution called Chlorhexidine can help people with chronic suprapubic catheters avoid urinary infections and improve their quality of life during catheter changes.

  Recruiting Yale University · New Haven, Connecticut · NCT06163469

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.